Keith Holliday net worth and biography

Keith Holliday Biography and Net Worth

Dr. Keith Holliday, Ph.D. serves as Chief Technology Officer of the Company. Dr. Keith Holliday joined STAAR in August 2015 as Vice President of Research and Development. In March 2017, he assumed the role of the Chief Technology Officer. From 2007 to his arrival at STAAR, he served as Vice President, Research and Development at ReVision Optics where he oversaw the development of their corneal inlay technology that includes a hydrogel inlay for presbyopia correction, delivery devices and clinical methodologies as well as managing first-in-man clinical studies. Previously, he was Director of Laser Technology at Advanced Medical Optics (AMO) and Staff Laser Scientist at VISX. Prior to joining VISX, Dr. Holliday worked primarily in academia. He obtained his first degree in Physics and Electronics from the University of Saint Andrews in Scotland and a Ph.D. from the Laser Physics Centre at the Australian National University. He spent three years at the Swiss Federal Institute of Technology, where he was primarily involved with the utilization of optically active polymers and crystals, to develop materials and techniques for very high density, holographic optical storage and computational systems. Dr. Holliday holds patents in excimer laser beam detection, control and profiling, and methods to correct presbyopia that synergistically take into account the epithelium’s response to corneal inlays, and he has also authored 37 peer reviewed publications in the scientific literature plus two book chapters and one single-authored book. He is considered an expert on presbyopia and served as a committee member for the International Society of Presbyopia.

What is Keith Holliday's net worth?

The estimated net worth of Keith Holliday is at least $1.76 million as of March 17th, 2023. Dr. Holliday owns 27,633 shares of STAAR Surgical stock worth more than $1,764,367 as of March 31st. This net worth evaluation does not reflect any other investments that Dr. Holliday may own. Learn More about Keith Holliday's net worth.

What is Keith Holliday's salary?

As the CTO of STAAR Surgical, Dr. Holliday earned a total compensation package of $1,269,606.00 in 2021. Dr. Holliday earned a salary of $420,690.00, a bonus of $373,990.00, stock awards of $223,329.00, options awards of $223,303.00, and other compensation of $28,294.00. Learn More on Keith Holliday's salary.

How do I contact Keith Holliday?

The corporate mailing address for Dr. Holliday and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at [email protected] Learn More on Keith Holliday's contact information.

Has Keith Holliday been buying or selling shares of STAAR Surgical?

Over the course of the past ninety days, Keith Holliday has sold $51,001.31 in shares of STAAR Surgical stock. Most recently, Keith Holliday sold 823 shares of the business's stock in a transaction on Friday, March 17th. The shares were sold at an average price of $61.97, for a transaction totalling $51,001.31. Following the completion of the sale, the chief technology officer now directly owns 27,633 shares of the company's stock, valued at $1,712,417.01. Learn More on Keith Holliday's trading history.

Who are STAAR Surgical's active insiders?

Are insiders buying or selling shares of STAAR Surgical?

During the last twelve months, STAAR Surgical insiders bought shares 2 times. They purchased a total of 91,075 shares worth more than $4,364,185.05. During the last twelve months, insiders at the medical instruments supplier sold shares 4 times. They sold a total of 87,830 shares worth more than $6,482,527.09. The most recent insider tranaction occured on March, 17th when CTO Keith Holliday sold 823 shares worth more than $51,001.31. Insiders at STAAR Surgical own 2.6% of the company. Learn More about insider trades at STAAR Surgical.

Information on this page was last updated on 3/17/2023.

Keith Holliday Insider Trading History at STAAR Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2023Sell823$61.97$51,001.3127,633View SEC Filing Icon  
8/15/2022Sell16,582$106.29$1,762,500.7819,437View SEC Filing Icon  
12/14/2021Sell6,000$89.57$537,420.00View SEC Filing Icon  
9/14/2020Sell35,689$53.32$1,902,937.4829,733View SEC Filing Icon  
5/15/2020Sell25,000$37.69$942,250.0053,447View SEC Filing Icon  
11/4/2019Sell2,100$35.00$73,500.0028,764View SEC Filing Icon  
3/22/2019Sell3,125$38.89$121,531.2540,239View SEC Filing Icon  
3/19/2019Sell2,084$36.22$75,482.4840,239View SEC Filing Icon  
3/22/2018Sell2,188$16.03$35,073.6443,781View SEC Filing Icon  
3/20/2018Sell1,458$16.05$23,400.9045,969View SEC Filing Icon  
11/21/2017Sell6,000$16.65$99,900.0045,969View SEC Filing Icon  
See Full Table

Keith Holliday Buying and Selling Activity at STAAR Surgical

This chart shows Keith Holliday's buying and selling at STAAR Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

STAAR Surgical Company Overview

STAAR Surgical logo
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Read More

Today's Range

Now: $63.95
Low: $62.74
High: $64.11

50 Day Range

MA: $65.27
Low: $55.39
High: $79.34

2 Week Range

Now: $63.95
Low: $46.35
High: $112.27


413,306 shs

Average Volume

762,239 shs

Market Capitalization

$3.08 billion

P/E Ratio


Dividend Yield